These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation. Sánchez Lázaro IJ, Almenar Bonet L, Moro López J, Sánchez Lacuesta E, Martínez-Dolz L, Agüero Ramón-Llín J, Andrés Lalaguna L, Cano Pérez O, Ortiz Martínez V, Buendía Fuentes F, Salvador Sanz A. Transplant Proc; 2008 Nov 14; 40(9):3056-7. PubMed ID: 19010192 [Abstract] [Full Text] [Related]
10. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma. Schvoerer E, Henriot S, Zachary P, Freitag R, Fuchs A, Fritsch S, Risch S, Meyer N, Caillard S, Lioure B, Stoll-Keller F. J Med Virol; 2005 May 14; 76(1):76-81. PubMed ID: 15778970 [Abstract] [Full Text] [Related]
13. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy. Martínez-Dolz L, Almenar L, Reganon E, Vila V, Chamorro C, Andrés L, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A. J Heart Lung Transplant; 2008 Jul 14; 27(7):760-6. PubMed ID: 18582806 [Abstract] [Full Text] [Related]